Senate FDA reform passed at last to industry acclaim, with vote on House proposals imminent
This article was originally published in Clinica
Executive Summary
The US Senate has finally approved its FDA reform bill, ending a three-year struggle to find a legislative balance between the speed of medical device and drug approvals and patient safety.